Riccardo Barrile

USPTO Granted Patents = 13 (Patent Applications = 11)

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 1 (Patent Applications = 6)

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

Children's Medical Center Corporation

patents

where one patent can have more than one assignee

Years Active: 2019-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12098352 - Stem cell-based lung-on-chip models (2024-09-24),

2. 11970680 - Devices, systems and methods for inhibiting invasion and metasases of cancer (2024-04-30),

3. 11833512 - In vitro epithelial models comprising lamina propria-derived cells (2023-12-05),

4. 11788044 - Rheologically biomimetic fluid surrogate (2023-10-17),

5. 11371000 - Devices, systems and methods for inhibiting invasion and metastases of cancer (2022-06-28),

6. 11150255 - Additive channels (2021-10-19),

7. 11059041 - In vitro epithelial models comprising lamina propria-derived cells (2021-07-13),

8. 10989721 - Additive channels (2021-04-27),

9. 10908171 - Additive channels (2021-02-02),

10. 10852311 - Additive channels (2020-12-01),

11. 10828638 - In vitro epithelial models comprising lamina propria-derived cells (2020-11-10),

12. 10732172 - Methods, systems, and compositions for determining blood clot formation, and uses thereof (2020-08-04),

13. 10228381 - Additive channels (2019-03-12),

Title: Riccardo Barrile: Innovator in Microfluidic Technologies

Introduction

Riccardo Barrile is a prominent inventor based in Boston, MA, known for his groundbreaking work in microfluidic technologies. With a total of 13 patents to his name, he has made significant contributions to the fields of biomedical engineering and cancer research. His innovative approaches have paved the way for new methods in disease modeling and therapeutic testing.

Latest Patents

Among his latest patents is the development of stem cell-based lung-on-chip models. This invention describes an in vitro microfluidic 'organ-on-chip' device that mimics the structure and function of specific areas of the epithelial system in vivo. The stem cell-based Lung-on-Chip can model the differentiation of cells into various lung cell types, such as bronchial and alveolar cells, for studying healthy and diseased tissues. Another notable patent focuses on devices, systems, and methods for inhibiting invasion and metastases of cancer. This invention relates to microfluidic platforms for testing cancer dynamics, allowing researchers to simulate tumor invasion and study interactions with immune cells.

Career Highlights

Riccardo Barrile has worked with notable organizations, including Emulate, Inc. and Harvard College. His work has been instrumental in advancing the understanding of complex biological systems through innovative microfluidic designs. His research has garnered attention for its potential applications in personalized medicine and cancer treatment.

Collaborations

Throughout his career, Barrile has collaborated with esteemed colleagues such as Antonio Varone and Geraldine A Hamilton. These partnerships have further enriched his research and contributed to the development of cutting-edge technologies in the biomedical field.

Conclusion

Riccardo Barrile's contributions to microfluidic technologies and cancer research exemplify the impact of innovation in modern science. His patents and collaborative efforts continue to influence the future of biomedical engineering and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.